Search Results for: MYCBP2

58 interactions involving MYCBP2 - MYC binding protein 2 found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Symbol Description Pathways Hide Drugs Hide Diseases Hide
DSCR9 Down syndrome critical region 9
DYRK1A dual specificity tyrosine phosphorylation regulated kinase 1A
  • G0 and Early G1
  • N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide
  • Fostamatinib
ERBB3 erb-b2 receptor tyrosine kinase 3
  • Tucatinib
  • Type I diabetes mellitus
  • Lethal congenital contractural syndrome (LCCS)
FHL3 four and a half LIM domains 3
FSCN1 fascin actin-bundling protein 1
  • Interleukin-4 and Interleukin-13 signaling
HSP90AB1 heat shock protein 90 alpha family class B member 1
  • DDX58/IFIH1-mediated induction of interferon-alpha/beta
  • Regulation of actin dynamics for phagocytic cup formation
  • HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand
  • HSF1 activation
  • Attenuation phase
  • HSF1-dependent transactivation
  • Sema3A PAK dependent Axon repulsion
  • Uptake and function of diphtheria toxin
  • Neutrophil degranulation
  • The NLRP3 inflammasome
  • The role of GTSE1 in G2/M progression after G2 checkpoint
  • Aryl hydrocarbon receptor signalling
  • ESR-mediated signaling
  • RHOBTB2 GTPase cycle
  • Estrogen-dependent gene expression
  • Chaperone Mediated Autophagy
  • Purinergic signaling in leishmaniasis infection
  • Potential therapeutics for SARS
  • SARS-CoV-2 activates/modulates innate and adaptive immune responses
  • Assembly and release of respiratory syncytial virus (RSV) virions
  • Respiratory syncytial virus genome replication
  • Geldanamycin
  • 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine
  • Radicicol
  • Tanespimycin
  • SNX-5422
  • CCT-018159
  • 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE
  • 4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL
  • (5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE
  • (5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE
  • (5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE
  • (5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE
  • METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE
  • 2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE
  • Polaprezinc
HUNK hormonally up-regulated Neu-associated kinase
IGFBP6 insulin like growth factor binding protein 6
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
LCOR ligand dependent nuclear receptor corepressor
LDHB lactate dehydrogenase B
  • Pyruvate metabolism
  • NADH
  • 4-Hydroxy-1,2,5-oxadiazole-3-carboxylic acid
  • Oxamic Acid
  • Stiripentol
  • Artenimol
LSM14A LSM14A mRNA processing body assembly factor
MYC MYC proto-oncogene, bHLH transcription factor
  • Transcription of E2F targets under negative control by DREAM complex
  • Signaling by ALK
  • NOTCH1 Intracellular Domain Regulates Transcription
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Binding of TCF/LEF:CTNNB1 to target gene promoters
  • MAPK6/MAPK4 signaling
  • Ub-specific processing proteases
  • Interleukin-4 and Interleukin-13 signaling
  • Cyclin E associated events during G1/S transition
  • Cyclin A:Cdk2-associated events at S phase entry
  • TFAP2 (AP-2) family regulates transcription of cell cycle factors
  • RUNX3 regulates WNT signaling
  • Estrogen-dependent gene expression
  • Transcriptional regulation of granulopoiesis
  • Regulation of CDH1 mRNA translation by microRNAs
  • Regulation of NFE2L2 gene expression
  • Regulation of PD-L1(CD274) transcription
  • Acetylsalicylic acid
  • Dimethyl sulfoxide
  • Doconexent
  • Nadroparin
  • Penile cancer
  • Breast cancer
  • Laryngeal cancer
  • Oral cancer
  • Multiple myeloma
  • Kaposi's sarcoma
  • Ovarian cancer
  • Choriocarcinoma
  • Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)
  • Burkitt lymphoma
  • Small cell lung cancer
  • Osteosarcoma
  • Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia)
NDUFB9 NADH:ubiquinone oxidoreductase subunit B9
  • Respiratory electron transport
  • Complex I biogenesis
  • NADH
NMNAT2 nicotinamide nucleotide adenylyltransferase 2
  • Nicotinate metabolism
OAZ1 ornithine decarboxylase antizyme 1
  • Regulation of ornithine decarboxylase (ODC)
  • Metabolism of polyamines
  • Ornithine
PABPN1 poly(A) binding protein nuclear 1
  • Inhibition of Host mRNA Processing and RNA Silencing
  • mRNA 3'-end processing
  • Processing of Capped Intron-Containing Pre-mRNA
  • RNA Polymerase II Transcription Termination
  • Processing of Intronless Pre-mRNAs
  • Z-decay: degradation of maternal mRNAs by zygotically expressed factors
  • Nuclear RNA decay
  • Oculopharyngeal muscular dystrophy (OPMD)
PI4KB phosphatidylinositol 4-kinase beta
  • Synthesis of PIPs at the Golgi membrane
  • Fostamatinib
PRXL2A peroxiredoxin like 2A
PTPN12 protein tyrosine phosphatase non-receptor type 12
  • SHC1 events in ERBB2 signaling
  • SHC1 events in ERBB2 signaling
  • EGFR downregulation
  • Signaling by PDGF
  • Downregulation of ERBB2 signaling
  • Interleukin-37 signaling
  • Constitutive Signaling by Overexpressed ERBB2
  • Tiludronic acid
PUF60 poly(U) binding splicing factor 60
  • mRNA Splicing - Major Pathway

Page 2 out of 3 pages